InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Forman Mark S. Officer active across 2 companies, notably Ventyx Biosciences, Inc.. Cumulatively, 5 reports have been logged. Activity tracked since 15 May 2025. The latest transaction was filed on 17 November 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Forman Mark S is Chief Medical Officer at Ventyx Biosciences, Inc. and CHIEF MEDICAL OFFICER at Passage BIO, Inc. He has 5 filings in total, with sampled filings ranging from 2024-01-03 to 2026-03-04. The buy and sell amounts observed in these recent filings are 0 and 0 EUR, and the most frequent transaction nature is Attribution.